Mangoceuticals Inc.

News & Events

Press Releases

In The Media

1. Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

   GlobeNewswire MAY 27, 2025 9:00 AM EDT
   Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals...
   READ ARTICLE

2. Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

   GlobeNewswire APR 25, 2025 9:00 AM EDT
   DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“ M...
   READ ARTICLE

3. CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

   ACCESS Newswire APR 22, 2025 1:55 PM EDT
   DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ: MGRX ) is on a mi...
   READ ARTICLE

4. Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

   GlobeNewswire MAR 25, 2025 9:00 AM EDT
   Diabetinol ® is a clinically supported and patented plant-based nutraceutical ...
   READ ARTICLE

5. Mangoceuticals Announces the Launch of "PeachesRx" - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

   GlobeNewswire FEB 20, 2025 7:00 AM EST
   Dallas, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceu...
   READ ARTICLE

6. Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

   GlobeNewswire FEB 12, 2025 8:00 AM EST
   Dallas, Texas, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Man...
   READ ARTICLE

7. Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

   GlobeNewswire FEB 6, 2025 7:00 AM EST
   Dallas, Texas, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Man...
   READ ARTICLE

8. Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®? Skincare Treatment Targeting Hyperpigmentation

   GlobeNewswire FEB 3, 2025 8:30 AM EST
   Dallas, TX & Quebec, Canada, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: ...
   READ ARTICLE

9. Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

   GlobeNewswire DEC 19, 2024 5:33 PM EST
   Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mang...
   READ ARTICLE

10. Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

    GlobeNewswire DEC 4, 2024 7:00 AM EST
    DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mang...
    READ ARTICLE